Found 9 matching trials
RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies EARLY_PHASE1 This is a single-arm, open-label, single-center, phase I study. The primary...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM EARLY_PHASE1 This is an open clinical pharmacological translational Research Study, aimi...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies EARLY_PHASE1 This is a single-arm, open-label, single-center, phase I study. The primary...
Show More Location
Union Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies PHASE1 This is a single-arm, open-label, single-center, phase I study. The primary...
Show More Learn More & Join Trial
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL EARLY_PHASE1 This is a single-arm, open-label, single-center, phase I study. The primary...
Show More Location
The First Affiliated Hospital of University of Science and Technology of China
Learn More & Join Trial
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL EARLY_PHASE1 This is a single-arm, open-label, single-center, phase I study. The primary...
Show More Location
The first affiliated hospital of medical college of zhejiang university
Learn More & Join Trial
Research Development(RD)13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7(CD7)+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) EARLY_PHASE1 This is a single-arm, open-label, single-center, phase I study. The primary...
Show More Location
Affiliated hospital of Xuzhou medical college
Learn More & Join Trial
CD7 CAR T Cells (RD13-02) in the Treatment of Relapsed/Refractory Severe Aplastic Anemia PHASE1 This trial is exploratory research aimed at evaluating the safety, tolerabi...
Show More Location
Regenerative Medicine Clinic Center
Learn More & Join Trial
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes EARLY_PHASE1 Type 1 diabetes mellitus (T1DM) is a T cell-mediated autoimmune disease cha...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial